Company
Lactiga
Lactiga™ is an award-winning, venture-backed biotechnology company developing innovative mucosal antibody therapies to advance the future of immunoscience.
Also known as Lactiga US, Inc
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Legal name
- Lactiga US, Inc
- lactiga.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
Lactiga™ is an award-winning, venture-backed biotechnology company developing innovative mucosal antibody therapies to advance the future of immunoscience. We are unlocking the full therapeutic value of human milk to create the world’s first platform for secretory IgA antibodies. Our groundbreaking approach has the potential to transform treatment for conditions like chronic respiratory disorders, gut inflammation, immune deficiencies, and more, positioning us at the forefront of immunotherapy innovation.
Funding snapshot
- Total raised
- $1.6MSum of rounds, as of 2026-09-20Source (opens in a new tab)
- Latest round
- Grant2025-02-03
Funding rounds
- Grant
- 2025-02-03
- Pre seed
- $1.6M2022-09-21, Company stated
- Seed
- 2020-11-02
Products
- Other
- LCTG-002
Loading relationship preview